Setting the Benchmark for KRASG12C -Mutated NSCLC

N Engl J Med. 2022 Jul 14;387(2):180-183. doi: 10.1056/NEJMe2207902.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Benchmarking
  • Carcinoma, Non-Small-Cell Lung* / drug therapy
  • Carcinoma, Non-Small-Cell Lung* / genetics
  • Humans
  • Lung Neoplasms* / drug therapy
  • Lung Neoplasms* / genetics
  • Mutation
  • Proto-Oncogene Proteins p21(ras)* / genetics

Substances

  • KRAS protein, human
  • Proto-Oncogene Proteins p21(ras)